Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
T Manabe, D Kambayashi, H Akatsu, K Kudo - BMC infectious diseases, 2021 - Springer
Background Favipiravir possesses high utility for treating patients with COVID-19. However,
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies
Objectives This study aimed to evaluate the efficacy and adverse events of favipiravir in
patients with COVID-19. Methods Our protocol was registered on PROSPERO …
patients with COVID-19. Methods Our protocol was registered on PROSPERO …
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
M AlQahtani, N Kumar, D Aljawder, A Abdulrahman… - Scientific Reports, 2022 - nature.com
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …
Soot-Based Reduced Graphene Quantum Dot/Hemin Conjugate for Favipiravir Sensing
I Hazarika, T Kalita, P Deka, SK Gogoi… - ACS Applied Nano …, 2021 - ACS Publications
A conjugated system was synthesized from reduced graphene quantum dot (rGQD) and
hemin for the selective detection of favipiravir (Fav), an antiviral drug that has come into …
hemin for the selective detection of favipiravir (Fav), an antiviral drug that has come into …
Potential Drug Interaction Between Favipiravir and Warfarin in Patients With COVID‐19: A Real‐World Observational Study
K Wattana, S Uitrakul, N Leesakulpisut… - The Journal of …, 2023 - Wiley Online Library
Favipiravir is one of the most used antiviral agents for the treatment of coronavirus disease
2019 infection in many countries, including Thailand. This study aimed to investigate the …
2019 infection in many countries, including Thailand. This study aimed to investigate the …
The safety profile of favipiravir in COVID‐19 patients with severe renal impairment
S Gök, ÖF Bahçecioğlu, M Durmuş… - … Journal of Clinical …, 2021 - Wiley Online Library
Objective The safety profile of favipiravir in patients with severe renal impairment has not
been investigated and available data are insufficient. The study aimed to compare the …
been investigated and available data are insufficient. The study aimed to compare the …
Effects of favipiravir on hematologic parameters and bone marrow in the rats
Favipiravir, a selective RNA polymerase inhibitor agent, is an antiviral drug currently used
effectively in treating pandemic diseases such as Covid-19. The present study aims to …
effectively in treating pandemic diseases such as Covid-19. The present study aims to …
Biochemical and histopathological evaluation of systemic and ocular toxicity of favipiravir in rats
D Özcan, F Özçelik, R Mammadov, M Aktaş… - Cutaneous and …, 2024 - Taylor & Francis
Purpose: Favipiravir (FAV) used against COVID-19 is an antiviral drug that causes adverse
reactions, such as hyperuricaemia, liver damage, and hematopoetic toxicity. The aim of the …
reactions, such as hyperuricaemia, liver damage, and hematopoetic toxicity. The aim of the …
Возможность и перспективы применения препарата фавипиравир у пациентов с COVID-19
АВ Матвеев, ЮЮ Киселёв… - Качественная …, 2020 - cyberleninka.ru
Существуют экспериментальные и клинические данные касательно активности
фавипиравира в отношении вируса SARS-CoV-2. Имеются сведения о значительной …
фавипиравира в отношении вируса SARS-CoV-2. Имеются сведения о значительной …
Мониторинг безопасности применения фавипиравира: управление рисками развития нежелательных лекарственных реакций в клинической практике
ЮЮ Киселёв, АВ Матвеев, КБ Мирзаев… - Качественная …, 2020 - cyberleninka.ru
Мировой опыт клинического применения фавипиравира весьма ограничен. Его
безопасность требует дальнейшего изучения. Принципиально значимо …
безопасность требует дальнейшего изучения. Принципиально значимо …